Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.130
-0.010 (-0.47%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Oramed Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2021 2020 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2020 - 2016
Cash & Equivalents
54.429.0640.4627.4677.25
Upgrade
Short-Term Investments
87.51152.99115.26118.8216.9
Upgrade
Cash & Short-Term Investments
141.93162.05155.72146.2894.14
Upgrade
Cash Growth
-12.41%4.06%6.45%55.39%-
Upgrade
Prepaid Expenses
1.290.541.391.661.2
Upgrade
Total Current Assets
143.22162.58157.11147.9495.34
Upgrade
Property, Plant & Equipment
1.111.571.80.890.93
Upgrade
Long-Term Investments
10.9156.372.73.886.69
Upgrade
Other Long-Term Assets
0.030.030.0325.1225.04
Upgrade
Total Assets
155.28220.55161.64177.82128
Upgrade
Accounts Payable
0.790.552.181.692.61
Upgrade
Accrued Expenses
1.481.381.972.311.2
Upgrade
Short-Term Debt
-51.01---
Upgrade
Current Portion of Leases
0.220.270.250.130.13
Upgrade
Current Income Taxes Payable
3.2----
Upgrade
Current Unearned Revenue
--1.342.72.7
Upgrade
Other Current Liabilities
--0.010.530.04
Upgrade
Total Current Liabilities
5.6953.215.757.376.68
Upgrade
Long-Term Leases
0.160.340.650.370.4
Upgrade
Long-Term Unearned Revenue
4443.344.24
Upgrade
Other Long-Term Liabilities
0.060.070.070.110.14
Upgrade
Total Liabilities
9.9357.6610.4911.2111.48
Upgrade
Common Stock
0.480.490.480.460.42
Upgrade
Additional Paid-In Capital
322.4320.89314.42292.51230.2
Upgrade
Retained Earnings
-176.62-157.56-163.08-126.52-114.85
Upgrade
Total Common Equity
146.27163.82151.81166.45115.77
Upgrade
Minority Interest
-0.92-0.93-0.660.160.74
Upgrade
Shareholders' Equity
145.35162.89151.16166.61116.52
Upgrade
Total Liabilities & Equity
155.28220.55161.64177.82128
Upgrade
Total Debt
0.3751.620.890.50.53
Upgrade
Net Cash (Debt)
141.56112.23154.83149.66100.3
Upgrade
Net Cash Growth
26.13%-27.51%3.45%49.21%-
Upgrade
Net Cash Per Share
3.472.773.974.033.52
Upgrade
Filing Date Shares Outstanding
40.8540.5239.7838.5638.09
Upgrade
Total Common Shares Outstanding
39.9240.3439.5638.1635.29
Upgrade
Working Capital
137.54109.37151.36140.5788.66
Upgrade
Book Value Per Share
3.664.063.844.363.28
Upgrade
Tangible Book Value
146.27163.82151.81166.45115.77
Upgrade
Tangible Book Value Per Share
3.664.063.844.363.28
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q